Table A3B.
Yogurt intake |
||
---|---|---|
Vaccine | Unadjusteda | Adjusted |
PCV7–4 | 2.74 (0.48, 15.65); p = 0.257 | 2.17 (0.35, 13.39); p = 0.404 |
PCV7–6B | 1.41 (0.41, 4.86); p = 0.589 | 1.11 (0.30, 4.11); p = 0.873 |
PCV7–9V | 1.47 (0.40, 5.45); p = 0.561 | 1.20 (0.31, 4.68); p = 0.797 |
PCV7–14 | 1.33 (0.35, 5.06); p = 0.679 | 1.33 (0.34, 5.25); p = 0.683 |
PCV7–18C | 0.96 (0.12, 7.38); p = 0.967 | 0.80 (0.10, 6.50); p = 0.834 |
PCV7–19F | 2.57 (0.80, 8.23); p = 0.112 | 2.20 (0.66, 7.30); p = 0.199 |
PCV7–23F | 2.78 (0.73, 10.62); p = 0.135 | 2.31 (0.57, 9.29); p = 0.238 |
Data represents the Odds Ratio and 95% confidence intervals; NA, not assessed due to co-linearity issues.
a Unadjusted analysis after removing missing data for yogurt intake (N = 25 LGG; N = 26 Placebo).